Evolutionary Tree Capital Management, LLC Krystal Biotech, Inc. Transaction History
Evolutionary Tree Capital Management, LLC
- $97.2 Million
- Q2 2024
A detailed history of Evolutionary Tree Capital Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Evolutionary Tree Capital Management, LLC holds 8,935 shares of KRYS stock, worth $1.62 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
8,935
Previous 9,096
1.77%
Holding current value
$1.62 Million
Previous $1.62 Million
1.36%
% of portfolio
1.69%
Previous 1.63%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
266Shares Held
25MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$716 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$521 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$442 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$242 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$185 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.66B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...